US Patent 11666574 Combination therapy involving diaryl macrocyclic compounds
All edits
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+220 characters)
US Patent 11666574 Combination therapy involving diaryl macrocyclic compounds
Article
The present disclosure relates to methods and compositions for treating cancer with a diaryl macrocycle in combination with an inhibitor of MAPK/ERK kinase-1 and -2 (MEK1 and MEK2; MAP2K1 and MAP2K2), such as trametinib.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116665740
Date of Patent
June 6, 2023
0Patent Application Number
171047390
Date Filed
November 25, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11666574 Combination therapy involving diaryl macrocyclic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
